Notably, Fas siRNA and DR4 siRNA transfection also partially abolished PL-induced inhibition of DNA binding activity of NF-κB in A549 and NCI-H460 NSCLC cells (Fig. 5d). The gene discussed is NFKB1; the disease is non-small cell lung carcinoma.